Evidence map›Paper›PMID 37214853›Full record

ArticlebioRxiv : the preprint server for biology2023

Adopting Duplex Sequencing™ Technology for Genetic Toxicity Testing: A Proof-of-Concept Mutagenesis Experiment with N-Ethyl-N-Nitrosourea (ENU)-Exposed Rats.

Stephanie L Smith-Roe, Cheryl A Hobbs, Victoria Hull, J Todd Auman, Leslie Recio, Michael A Streicker, Miriam V Rivas, Gabriel A Pratt, Fang Yin Lo, Jacob E Higgins and 6 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Stephanie L Smith-RoeDivision of Translational Toxicology, NIEHS, Research Triangle Park, NC.ORCID 0000-0001-7208-159X
Cheryl A HobbsIntegrated Laboratory Systems, LLC (an Inotiv company), Research Triangle Park, NC.ORCID 0000-0003-1125-0868
Victoria HullIntegrated Laboratory Systems, LLC (an Inotiv company), Research Triangle Park, NC.ORCID 0000-0002-2650-4392
J Todd AumanIntegrated Laboratory Systems, LLC (an Inotiv company), Research Triangle Park, NC.ORCID 0000-0002-9328-8829
Leslie RecioIntegrated Laboratory Systems, LLC (an Inotiv company), Research Triangle Park, NC.ORCID 0000-0003-4392-6412
Michael A StreickerIntegrated Laboratory Systems, LLC (an Inotiv company), Research Triangle Park, NC.
Miriam V RivasIntegrated Laboratory Systems, LLC (an Inotiv company), Research Triangle Park, NC.ORCID 0000-0002-5620-1632
Gabriel A PrattTwinStrand Biosciences, Inc., Seattle, WA.ORCID 0000-0003-1670-4507
Fang Yin LoTwinStrand Biosciences, Inc., Seattle, WA.ORCID 0000-0002-8974-6508
Jacob E HigginsTwinStrand Biosciences, Inc., Seattle, WA.ORCID 0000-0002-4984-5456
Elizabeth K SchmidtTwinStrand Biosciences, Inc., Seattle, WA.ORCID 0000-0001-9572-8368
Lindsey N WilliamsTwinStrand Biosciences, Inc., Seattle, WA.ORCID 0000-0003-3757-2582
Daniela NachmansonTwinStrand Biosciences, Inc., Seattle, WA.ORCID 0000-0001-9792-379X
Charles C ValentineTwinStrand Biosciences, Inc., Seattle, WA.ORCID 0000-0001-5630-7368
Jesse J SalkTwinStrand Biosciences, Inc., Seattle, WA.ORCID 0000-0002-7804-0550
Kristine L WittDivision of Translational Toxicology, NIEHS, Research Triangle Park, NC.ORCID 0000-0002-3827-6884
Triangle · US

Funding

Development of a Genotoxicity Assay using Duplex SequencingR44ES030642 · NIEHS · TWINSTRAND BIOSCIENCES, INC. · PI SALK, JESSE J · 2019 to 2021
$1.7M
NIEHS NIH HHS HHSN273201300009CNIEHS NIH HHS R44 ES030642
6 · The paper itself

Abstract

Duplex sequencing (DuplexSeq) is an error-corrected next-generation sequencing (ecNGS) method in which molecular barcodes informatically link PCR-copies back to their source DNA strands, enabling computational removal of errors by comparing grouped strand sequencing reads. The resulting background of less than one artifactual mutation per 10 HIGHLIGHTS: DuplexSeq is an ultra-accurate NGS technology that directly quantifies mutationsENU-dependent mutagenesis was detected 24 h post-exposure in proliferative tissuesMultiple tissues exhibited the canonical ENU mutation spectrum 7 d after exposureResults obtained with DuplexSeq were highly concordant between laboratoriesThe Rat-50 Mutagenesis Assay is promising for applications in genetic toxicology.

Identifiers

PMID37214853
PMCPMC10197591
OpenAlexW4376113741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.